Last updated on May 2019

The RENEW Trial: A Multi-Center Randomized Double-Masked Parallel-Group Vehicle-Controlled Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease


Brief description of study

The RENEW Trial is a Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap 0.25% Ophthalmic Solution Compared to Vehicle in Subjects with Dry Eye Disease

Clinical Study Identifier: NCT03879863

Find a site near you

Start Over

Eye Research Foundation

Newport Beach, CA United States
  Connect »